Skip to main content
. Author manuscript; available in PMC: 2024 May 13.
Published in final edited form as: Hepatology. 2019 Feb 9;69(3):1287–1299. doi: 10.1002/hep.30314

TABLE 2.

Mechanisms Behind Altered PKs in Patients With Cirrhosis and PH

Mechanism Comments

1 Reduced intrinsic capacity
 - Decreased enzyme levels
 - Decreased activity
Liver disease etiology–specific variability in different CYPs may exist—for example, alcohol and infection can affect some CYPs selectively
2 Reduction in blood flow May affect drug disposition through a number of mechanisms
3 Shunts Intrahepatic shunts—may account for up to 65% of hepatic blood flow
Spontaneous portosystemic shunts and TIPS can significantly modify
4 Changes in protein binding Impacts delivery of drugs to hepatocytes and can also have an impact on PD response
5 Reduced delivery of oxygen Oxygen is important for CYP activity
6 Altered transporter expression and function Hepatocyte uptake as well as efflux into biliary canaliculi can be affected
7 Small bowel CYP activity TIPS significantly reduces small bowel CYP3A activity
8 Drug-drug interactions Altered PKs of one compound may have secondary effects on the PKs of coadminstered drugs
9 Impaired renal function PKs of renally excreted drugs may be profoundly affected in individuals with cirrhosis
10 Altered intestinal absorption There may be diminished absorption of orally administered drugs and may also influence the PKs of drugs which are bile excreted because of impaired enterohepatic circulation

Abbreviations: CYP, cytochrome P450; TIPS, transjugular intrahepatic portosystemic shunts.